Peck Ronald

Peck Ronald serves as the Chief Medical Officer at Arvinas, Inc., a company focused on developing innovative therapies for cancer and other diseases. His recent insider trading activity, as reported on SEC Form 4, includes significant sale transactions as of February 27, 2024. The disclosed activity highlights a sale valued at approximately $2.7 million, marking a notable event in his trading history, with a total of three disclosures linked exclusively to Arvinas, Inc. (ARVN).